| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 77,295,261 | 177,412,278 | 104,006,633 | | Cost of Revenue |
-
| 901,415 |
-
| | | Gross Profit | 77,295,261 | 176,510,863 | 104,006,633 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 75,256,835 | 162,391,644 | 136,433,201 | | Non Recurring | (23,965) | 1,586,313 | (7,922) | | Others | 554,012 | 525,825 | 345,919 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,508,379 | 12,007,081 | (32,764,565) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (965,645) | (674,588) | 41,133,947 | | Earnings Before Interest And Taxes | 572,338 | 11,333,966 | 8,414,272 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 572,338 | 11,333,966 | 8,414,272 | | Income Tax Expense | (1,170,051) | 2,626,181 | 2,697,373 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,742,389 | 8,706,312 | 5,716,899 | | | Non-recurring Events | | Discontinued Operations |
-
| 706,992 |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,742,389 | 9,413,304 | 5,716,899 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,742,389 | $9,413,304 | $5,716,899 |
|
1.48% Nasdaq 
Income Statement
